GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (BOM:890202) » Definitions » Gross Profit

Solara Active Pharma Sciences (BOM:890202) Gross Profit : ₹3,888 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solara Active Pharma Sciences Gross Profit?

Solara Active Pharma Sciences's gross profit for the three months ended in Sep. 2024 was ₹1,751 Mil. Solara Active Pharma Sciences's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ₹3,888 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Solara Active Pharma Sciences's gross profit for the three months ended in Sep. 2024 was ₹1,751 Mil. Solara Active Pharma Sciences's Revenue for the three months ended in Sep. 2024 was ₹3,470 Mil. Therefore, Solara Active Pharma Sciences's Gross Margin % for the quarter that ended in Sep. 2024 was 50.46%.

Solara Active Pharma Sciences had a gross margin of 50.46% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 8 years, the highest Gross Margin % of Solara Active Pharma Sciences was 52.16%. The lowest was 32.29%. And the median was 44.73%.

Warning Sign:

Solara Active Pharma Sciences Ltd gross margin has been in long-term decline. The average rate of decline per year is -6.7%.


Solara Active Pharma Sciences Gross Profit Historical Data

The historical data trend for Solara Active Pharma Sciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Gross Profit Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial 6,440.20 8,218.80 5,492.30 5,659.70 3,998.80

Solara Active Pharma Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,877.10 332.10 186.40 1,619.20 1,750.60

Competitive Comparison of Solara Active Pharma Sciences's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's Gross Profit falls into.



Solara Active Pharma Sciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Solara Active Pharma Sciences's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=12383.9 - 8385.1
=3,999

Solara Active Pharma Sciences's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=3469.5 - 1718.9
=1,751

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,888 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Solara Active Pharma Sciences's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=1,751 / 3469.5
=50.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Solara Active Pharma Sciences  (BOM:890202) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Solara Active Pharma Sciences had a gross margin of 50.46% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Solara Active Pharma Sciences Gross Profit Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences Business Description

Comparable Companies
Traded in Other Exchanges
Address
27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines